This study, called the TAP Trial, is looking at whether low-dose aspirin (81 mg) can help women recover after experiencing preeclampsia (a serious high blood pressure condition during pregnancy). You would receive either low-dose aspirin or a placebo (an inactive pill that looks the same) daily for six months after delivery. The main goal of this pilot study is to see if it's practical to conduct a larger trial like this and to assess if aspirin helps improve blood vessel function and lower blood pressure. To join, you must be a woman between 18 and 55 years old who has recently had preeclampsia. You cannot participate if you have certain conditions like pre-pregnancy high blood pressure or diabetes, or an allergy to aspirin. The study is currently unclear about its recruitment status and plans to enroll 60 participants.

Study design

This is a pilot, randomized, double-blind study where 60 participants will be assigned by chance to receive either low-dose aspirin or a placebo. Neither you nor your doctor will know which you are receiving.

What's involved

You would take a pill daily for six months and monitor your blood pressure at home. You would also have three study visits involving blood pressure measurements, blood draws, questionnaires, and a test called microiontophoresis.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for approximately 6 months postpartum.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.